Cargando…

The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma

The effects of radiotherapy on hepatocellular carcinoma (HCC) still remain to be further proved. The dose of radiotherapy is generally 2Gy*25f. In the current study, we prospectively investigated the clinical outcomes of advanced or recurrent HCC patients who received hypofractionated radiotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Jie, Yan, Jing, Zhu, Sihui, Kong, Weiwei, Zou, Zhengyun, Liu, Juan, Li, Shuangshuang, Liu, Baorui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201615/ https://www.ncbi.nlm.nih.gov/pubmed/34136374 http://dx.doi.org/10.3389/fonc.2021.559112

Ejemplares similares

Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
por: Shi, Zhan, et al.
Publicado: (2022)

Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting
por: Elson, Andrew, et al.
Publicado: (2015)

Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
por: Jo, In-Young, et al.
Publicado: (2014)

AGIG Chemo-Immunotherapy in Patients With Advanced Pancreatic Cancer: A Single-Arm, Single-Center, Phase 2 Study
por: Dai, Wangshu, et al.
Publicado: (2021)

Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Ji-Yoon, et al.
Publicado: (2013)

Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer
por: Du, Juan, et al.
Publicado: (2022)

A Retrospective Study of Lenvatinib Monotherapy or Combined With Programmed Cell Death Protein 1 Antibody in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma in China
por: Zhu, Sihui, et al.
Publicado: (2021)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Hypofractionated whole breast irradiation with simultaneous integrated boost in breast cancer using helical tomotherapy with or without regional nodal irradiation: A report of acute toxicities
por: Chitapanarux, Imjai, et al.
Publicado: (2023)

Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy
por: Chang, Heng-Jui, et al.
Publicado: (2012)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Dosimetric Comparison of Helical Tomotherapy, Volume-Modulated Arc Therapy, and Fixed-Field Intensity-Modulated Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma
por: Lu, Shan, et al.
Publicado: (2021)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
por: Sayan, Mutlay, et al.
Publicado: (2019)

Hypofractionated electron-beam radiation therapy for keloids: retrospective study of 568 cases with 834 lesions
por: Shen, Jie, et al.
Publicado: (2015)

Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium
por: Dincer, Neris, et al.
Publicado: (2022)

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions
por: Laine, Aaron Michael, et al.
Publicado: (2016)

Adaptive Tomotherapy for locally advanced unresectable pancreatic neuroendocrine tumor: Case report and literature review
por: Tu, Kuan-Yi, et al.
Publicado: (2022)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

Treatment of Single or Multiple Brain Metastases by Hypofractionated Stereotactic Radiotherapy Using Helical Tomotherapy
por: Nagai, Aiko, et al.
Publicado: (2014)

Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients
por: Chitapanarux, Imjai, et al.
Publicado: (2019)

Tomotherapy-based moderate hypofractionation for localized prostate cancer: a mono-institutional analysis
por: Tenti, Maria Valentina, et al.
Publicado: (2022)

Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma
por: Seyedin, Steven N., et al.
Publicado: (2020)

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
por: Bearz, Alessandra, et al.
Publicado: (2013)

Comparison of clinical outcomes between cone beam CT-guided thermal ablation and helical tomotherapy in pulmonary metastases from hepatocellular carcinoma
por: Wang, Feihang, et al.
Publicado: (2022)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Dash, Chiranjeev, et al.
Publicado: (2012)

The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody
por: Liu, Chenxi, et al.
Publicado: (2022)

Volumetric modulated arc therapy versus tomotherapy for late T-stage nasopharyngeal carcinoma
por: Chen, Qian, et al.
Publicado: (2022)

Influencing Factors of Total Skin Irradiation With Helical Tomotherapy
por: Wang, Haiyang, et al.
Publicado: (2022)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

Combined helical tomotherapy and Gamma Knife stereotactic radiosurgery for high-grade recurrent orbital meningioma: a case report
por: Zhang, Haomiao, et al.
Publicado: (2023)

Identification of a novel gene signature for the prediction of recurrence in HCC patients by machine learning of genome-wide databases
por: Shen, Jie, et al.
Publicado: (2020)

Application of Helical Tomotherapy for Two Cases of Advanced Hepatocellular Carcinoma
por: Kim, Joon Sung, et al.
Publicado: (2011)

Corrigendum: Comparison of clinical outcomes between cone beam CT-guided thermal ablation and helical tomotherapy in pulmonary metastases from hepatocellular carcinoma
por: Wang, Feihang, et al.
Publicado: (2022)

Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis
por: Liao, Guixiang, et al.
Publicado: (2019)

Image Guided Hypofractionated Radiotherapy by Helical Tomotherapy for Prostate Carcinoma: Toxicity and Impact on Nadir PSA
por: Barra, Salvina, et al.
Publicado: (2014)

Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer
por: Serra, Marcello, et al.
Publicado: (2020)

Helical TomoTherapy for locally advanced or recurrent breast cancer
por: Duma, M. N., et al.
Publicado: (2017)

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial
por: Ye, Hua, et al.
Publicado: (2021)

Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer
por: Quackenbush, Kevin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6o8ts1k3190jrpn4jso88noatl